BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akl MR, Nagpal P, Ayoub NM, Tai B, Prabhu SA, Capac CM, Gliksman M, Goy A, Suh KS. Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies. Oncotarget 2016;7:44735-62. [PMID: 27007053 DOI: 10.18632/oncotarget.8203] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 18.5] [Reference Citation Analysis]
Number Citing Articles
1 Kang D, Jung SH, Lee GH, Lee S, Park HJ, Ko YG, Kim YN, Lee JS. Sulfated syndecan 1 is critical to preventing cellular senescence by modulating fibroblast growth factor receptor endocytosis. FASEB J 2020;34:10316-28. [PMID: 32530114 DOI: 10.1096/fj.201902714R] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
2 Kasuya A, Phadungsaksawasdi P, Imura K, Miyazawa H, Tokura Y. Capsule‐like naevus: digital 3D reconstruction of its steric structure. J Eur Acad Dermatol Venereol 2019;34. [DOI: 10.1111/jdv.15895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Pallotta MT, Nickel W. FGF2 and IL-1β – explorers of unconventional secretory pathways at a glance. Journal of Cell Science 2020;133:jcs250449. [DOI: 10.1242/jcs.250449] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Hu P, Chen H, Mcgowan EM, Ren N, Xu M, Lin Y. Assessment of FGFR1 Over-Expression and Over-Activity in Lung Cancer Cells: A Toolkit for Anti-FGFR1 Drug Screening. Human Gene Therapy Methods 2018;29:30-43. [DOI: 10.1089/hgtb.2017.104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
5 Li J, Han T, Wang X, Wang Y, Chen X, Chen W, Yang Q. Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer. Front Genet 2022;13:851373. [DOI: 10.3389/fgene.2022.851373] [Reference Citation Analysis]
6 Wang S, Qin Y, Wang Z, Xiang J, Zhang Y, Xu M, Li B, Xia Y, Zhang P, Wang H. Construction of a human monoclonal antibody against bFGF for suppression of NSCLC. J Cancer 2018;9:2003-11. [PMID: 29896285 DOI: 10.7150/jca.24255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Kang T, Yau C, Wong CK, Sanborn JZ, Newton Y, Vaske C, Benz SC, Krings G, Camarda R, Henry JE, Stuart J, Powell M, Benz CC. A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population. Breast Cancer Res 2020;22:81. [PMID: 32736587 DOI: 10.1186/s13058-020-01322-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
8 Manousakidi S, Guillaume A, Pirou C, Bouleau S, Mignotte B, Renaud F, Le Floch N. FGF1 induces resistance to chemotherapy in ovarian granulosa tumor cells through regulation of p53 mitochondrial localization. Oncogenesis 2018;7:18. [PMID: 29467390 DOI: 10.1038/s41389-018-0033-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
9 Huang W, Shu C, Hua L, Zhao Y, Xie H, Qi J, Gao F, Gao R, Chen Y, Zhang Q, Li W, Yuan M, Ye C, Ma Y. Modified bacterial outer membrane vesicles induce autoantibodies for tumor therapy. Acta Biomater 2020;108:300-12. [PMID: 32251780 DOI: 10.1016/j.actbio.2020.03.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
10 Meng Y, Bai X, Huang Y, He L, Zhang Z, Li X, Cui D, Yang X. Basic fibroblast growth factor signalling regulates cancer stem cells in lung cancer A549 cells. J Pharm Pharmacol 2019;71:1412-20. [PMID: 31282010 DOI: 10.1111/jphp.13136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Dräger O, Metz K, Busch M, Dünker N. Role of L1CAM in retinoblastoma tumorigenesis: identification of novel therapeutic targets. Mol Oncol 2021. [PMID: 34228897 DOI: 10.1002/1878-0261.13054] [Reference Citation Analysis]
12 Sakai H, Inoue H, Murata K, Toba T, Shimmyo Y, Narii N, Ueno SY, Igawa Y, Takemoto N. Fibroblast growth factor receptor modulators employing diamines with reduced phospholipidosis-inducing potential. Bioorg Med Chem 2020;28:115562. [PMID: 32616184 DOI: 10.1016/j.bmc.2020.115562] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Dimou E, Cosentino K, Platonova E, Ros U, Sadeghi M, Kashyap P, Katsinelos T, Wegehingel S, Noé F, García-Sáez AJ, Ewers H, Nickel W. Single event visualization of unconventional secretion of FGF2. J Cell Biol 2019;218:683-99. [PMID: 30470711 DOI: 10.1083/jcb.201802008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
14 Zhang W, Zhou Y, Li C, Xu S, Li M, Liu W, Ma Y, Wang H. The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma. Anal Cell Pathol (Amst) 2020;2020:2872479. [PMID: 33381388 DOI: 10.1155/2020/2872479] [Reference Citation Analysis]
15 McNiel EA, Tsichlis PN. Analyses of publicly available genomics resources define FGF-2-expressing bladder carcinomas as EMT-prone, proliferative tumors with low mutation rates and high expression of CTLA-4, PD-1 and PD-L1. Signal Transduct Target Ther 2017;2:16045. [PMID: 28515962 DOI: 10.1038/sigtrans.2016.45] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
16 Martínez-Barriocanal Á, Arango D, Dopeso H. PVT1 Long Non-coding RNA in Gastrointestinal Cancer. Front Oncol 2020;10:38. [PMID: 32083000 DOI: 10.3389/fonc.2020.00038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
17 Lolicato F, Nickel W. A Role for Liquid-Ordered Plasma Membrane Nanodomains Coordinating the Unconventional Secretory Pathway of Fibroblast Growth Factor 2? Front Cell Dev Biol 2022;10:864257. [DOI: 10.3389/fcell.2022.864257] [Reference Citation Analysis]
18 Chande S, Bergwitz C. Role of phosphate sensing in bone and mineral metabolism. Nat Rev Endocrinol 2018;14:637-55. [PMID: 30218014 DOI: 10.1038/s41574-018-0076-3] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 18.3] [Reference Citation Analysis]
19 Revuelta J, Fraile I, Monterrey DT, Peña N, Benito-Arenas R, Bastida A, Fernández-Mayoralas A, García-Junceda E. Heparanized chitosans: towards the third generation of chitinous biomaterials. Mater Horiz 2021;8:2596-614. [PMID: 34617543 DOI: 10.1039/d1mh00728a] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 O'Halloran N, Khan S, Gilligan K, Dwyer R, Kerin M, Lowery A. Oncological Risk in Autologous Stem Cell Donation for Novel Tissue-Engineering Approaches to Postmastectomy Breast Regeneration. Breast Cancer (Auckl) 2019;13:1178223419864896. [PMID: 31555047 DOI: 10.1177/1178223419864896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Nisar S, Yousuf P, Masoodi T, Wani NA, Hashem S, Singh M, Sageena G, Mishra D, Kumar R, Haris M, Bhat AA, Macha MA. Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment. Int J Mol Sci 2021;22:4584. [PMID: 33925575 DOI: 10.3390/ijms22094584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Calaf GM, Bleak TC, Roy D. Signs of carcinogenicity induced by parathion, malathion, and estrogen in human breast epithelial cells (Review). Oncol Rep 2021;45:24. [PMID: 33649804 DOI: 10.3892/or.2021.7975] [Reference Citation Analysis]
23 Weidle UH, Birzele F, Brinkmann U, Auslaender S. Gastric Cancer: Identification of microRNAs Inhibiting Druggable Targets and Mediating Efficacy in Preclinical In Vivo Models. Cancer Genomics Proteomics 2021;18:497-514. [PMID: 34183383 DOI: 10.21873/cgp.20275] [Reference Citation Analysis]
24 Lee J, Ye Y. The Roles of Endo-Lysosomes in Unconventional Protein Secretion. Cells 2018;7:E198. [PMID: 30400277 DOI: 10.3390/cells7110198] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
25 Jiang X, Huang Y, Wang X, Liang Q, Li Y, Li F, Fu X, Huang C, Liu H. Dianhydrogalactitol, a potential multitarget agent, inhibits glioblastoma migration, invasion, and angiogenesis. Biomed Pharmacother 2017;91:1065-74. [PMID: 28525947 DOI: 10.1016/j.biopha.2017.05.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
26 Marques P, Barry S, Carlsen E, Collier D, Ronaldson A, Grieve J, Dorward N, Mendoza N, Nair R, Muquit S, Grossman AB, Korbonits M. The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours. J Neuroendocrinol 2021;:e13052. [PMID: 34708902 DOI: 10.1111/jne.13052] [Reference Citation Analysis]
27 Santolla MF, Talia M, Maggiolini M. S100A4 Is Involved in Stimulatory Effects Elicited by the FGF2/FGFR1 Signaling Pathway in Triple-Negative Breast Cancer (TNBC) Cells. Int J Mol Sci 2021;22:4720. [PMID: 33946884 DOI: 10.3390/ijms22094720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Sparn C, Meyer A, Saleppico R, Nickel W. Unconventional secretion mediated by direct protein self-translocation across the plasma membranes of mammalian cells. Trends Biochem Sci 2022:S0968-0004(22)00086-X. [PMID: 35490075 DOI: 10.1016/j.tibs.2022.04.001] [Reference Citation Analysis]
29 Lyes MA, Payne S, Ferrell P, Pizzo SV, Hollenbeck ST, Bachelder RE. Adipose stem cell crosstalk with chemo-residual breast cancer cells: implications for tumor recurrence. Breast Cancer Res Treat 2019;174:413-22. [PMID: 30594967 DOI: 10.1007/s10549-018-05103-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
30 Gan Y, Sun Y, Jin J, Wang Y, Chen J, Chung Y, Li X, Ye H. bFGF could be a biomarker of malignancy in RS3PE syndrome: an ambispective single-center cohort analysis of 51 patients. Arthritis Res Ther 2021;23:261. [PMID: 34654466 DOI: 10.1186/s13075-021-02638-0] [Reference Citation Analysis]
31 Bin X, Lin C, Huang X, Zhou Q, Wang L, Xian CJ. FGF-2 Gene Polymorphism in Osteoporosis among Guangxi's Zhuang Chinese. Int J Mol Sci 2017;18:E1358. [PMID: 28653999 DOI: 10.3390/ijms18071358] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Ma M, Li H, Wang P, Yang W, Mi R, Zhuang J, Jiang Y, Lu Y, Shen X, Wu Y, Shen H. ATF6 aggravates angiogenesis-osteogenesis coupling during ankylosing spondylitis by mediating FGF2 expression in chondrocytes. iScience 2021;24:102791. [PMID: 34296071 DOI: 10.1016/j.isci.2021.102791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Wu B, Tang X, Zhou Z, Ke H, Tang S, Ke R. RNA sequencing analysis of FGF2-responsive transcriptome in skin fibroblasts. PeerJ 2021;9:e10671. [PMID: 33520460 DOI: 10.7717/peerj.10671] [Reference Citation Analysis]
34 Caiado H, Conceição N, Tiago D, Marreiros A, Vicente S, Enriquez JL, Vaz AM, Antunes A, Guerreiro H, Caldeira P, Cancela ML. Data on the evaluation of FGF2 gene expression in Colorectal Cancer. Data Brief 2020;31:105765. [PMID: 32551343 DOI: 10.1016/j.dib.2020.105765] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Fu XF, Zhao HC, Yang CL, Chen CZ, Wang K, Gao F, Tian YZ, Zhao HL. MicroRNA-203-3p inhibits the proliferation, invasion and migration of pancreatic cancer cells by downregulating fibroblast growth factor 2. Oncol Lett 2021;22:626. [PMID: 34267818 DOI: 10.3892/ol.2021.12887] [Reference Citation Analysis]
36 Kowalczuk O, Laudanski J, Laudanski W, Niklinska WE, Kozlowski M, Niklinski J. Lymphatics-associated genes are downregulated at transcription level in non-small cell lung cancer. Oncol Lett 2018;15:6752-62. [PMID: 29849784 DOI: 10.3892/ol.2018.8159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
37 Legrand C, Saleppico R, Sticht J, Lolicato F, Müller HM, Wegehingel S, Dimou E, Steringer JP, Ewers H, Vattulainen I, Freund C, Nickel W. The Na,K-ATPase acts upstream of phosphoinositide PI(4,5)P2 facilitating unconventional secretion of Fibroblast Growth Factor 2. Commun Biol 2020;3:141. [PMID: 32214225 DOI: 10.1038/s42003-020-0871-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
38 Yuan XZ, Sun S, Tan CC, Yu JT, Tan L. The Role of ADAM10 in Alzheimer's Disease. J Alzheimers Dis 2017;58:303-22. [PMID: 28409746 DOI: 10.3233/JAD-170061] [Cited by in Crossref: 45] [Cited by in F6Publishing: 29] [Article Influence: 11.3] [Reference Citation Analysis]
39 Steringer JP, Nickel W. A direct gateway into the extracellular space: Unconventional secretion of FGF2 through self-sustained plasma membrane pores. Semin Cell Dev Biol 2018;83:3-7. [PMID: 29458182 DOI: 10.1016/j.semcdb.2018.02.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
40 Auriau J, Roujeau C, Belaid Choucair Z, Oishi A, Derviaux C, Roux T, Trinquet E, Hermine O, Jockers R, Dam J. Gain of affinity for VEGF165 binding within the VEGFR2/NRP1 cellular complex detected by an HTRF-based binding assay. Biochem Pharmacol 2018;158:45-59. [PMID: 30236477 DOI: 10.1016/j.bcp.2018.09.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
41 Sakai H, Inoue H, Toba T, Murata K, Narii N, Shimmyo Y, Igawa Y, Matsumoto T, Takemoto N. Discovery of 1,2,3-triazole-based fibroblast growth factor receptor modulators. Bioorganic & Medicinal Chemistry Letters 2019;29:2332-7. [DOI: 10.1016/j.bmcl.2019.06.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Liu D, Zhang T, Chen X, Zhang B, Wang Y, Xie M, Ji X, Sun M, Huang W, Xia L. ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY. Cell Death Dis 2021;12:1113. [PMID: 34839358 DOI: 10.1038/s41419-021-04410-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Steringer JP, Lange S, Čujová S, Šachl R, Poojari C, Lolicato F, Beutel O, Müller HM, Unger S, Coskun Ü, Honigmann A, Vattulainen I, Hof M, Freund C, Nickel W. Key steps in unconventional secretion of fibroblast growth factor 2 reconstituted with purified components. Elife 2017;6:e28985. [PMID: 28722655 DOI: 10.7554/eLife.28985] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
44 Mahmood HA, Tomas Bort E, Walker AJ, Grose RP, Chioni AM. FGF signalling facilitates cervical cancer progression. FEBS J 2021. [PMID: 34951738 DOI: 10.1111/febs.16331] [Reference Citation Analysis]
45 Bahmad HF, Jalloul M, Azar J, Moubarak MM, Samad TA, Mukherji D, Al-Sayegh M, Abou-Kheir W. Tumor Microenvironment in Prostate Cancer: Toward Identification of Novel Molecular Biomarkers for Diagnosis, Prognosis, and Therapy Development. Front Genet 2021;12:652747. [PMID: 33841508 DOI: 10.3389/fgene.2021.652747] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
46 Ahmed M, Legrand C, Yagüe Relimpio A, Beretta CA, Muschko A, Wegehingel S, Müller HM, Sehr P, Will DW, Lewis JD, Nickel W. A time-resolved live cell imaging assay to identify small molecule inhibitors of FGF2 signaling. FEBS Lett 2019;593:2162-76. [PMID: 31135968 DOI: 10.1002/1873-3468.13462] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Eguchi R, Wakabayashi I. HDGF enhances VEGF‑dependent angiogenesis and FGF‑2 is a VEGF‑independent angiogenic factor in non‑small cell lung cancer. Oncol Rep 2020;44:14-28. [PMID: 32319650 DOI: 10.3892/or.2020.7580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
48 Vigano S, Alatzoglou D, Irving M, Ménétrier-Caux C, Caux C, Romero P, Coukos G. Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function. Front Immunol 2019;10:925. [PMID: 31244820 DOI: 10.3389/fimmu.2019.00925] [Cited by in Crossref: 118] [Cited by in F6Publishing: 113] [Article Influence: 39.3] [Reference Citation Analysis]
49 Kaulins R, Rozite LR, Pilmane M, Petersons A. Morphofunctional Characterization of Different Tissue Factors in Congenital Diaphragmatic Hernia Affected Tissue. Diagnostics (Basel) 2021;11:289. [PMID: 33673194 DOI: 10.3390/diagnostics11020289] [Reference Citation Analysis]
50 Šachl R, Čujová S, Singh V, Riegerová P, Kapusta P, Müller HM, Steringer JP, Hof M, Nickel W. Functional Assay to Correlate Protein Oligomerization States with Membrane Pore Formation. Anal Chem 2020;92:14861-6. [PMID: 33198473 DOI: 10.1021/acs.analchem.0c03276] [Reference Citation Analysis]
51 Imagama S, Ogino R, Ueno S, Murayama N, Takemoto N, Shimmyo Y, Kadoshima T, Tamura S, Kuroda M, Matsuyama Y, Kadomatsu K, Morita Y, Inoue T, Ishiguro N. Systemic treatment with a novel basic fibroblast growth factor mimic small-molecule compound boosts functional recovery after spinal cord injury. PLoS One 2020;15:e0236050. [PMID: 32678832 DOI: 10.1371/journal.pone.0236050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Benington L, Rajan G, Locher C, Lim LY. Fibroblast Growth Factor 2-A Review of Stabilisation Approaches for Clinical Applications. Pharmaceutics 2020;12:E508. [PMID: 32498439 DOI: 10.3390/pharmaceutics12060508] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
53 Vellanki S, Huh EY, Saville SP, Lee SC. Candida albicans Morphology-Dependent Host FGF-2 Response as a Potential Therapeutic Target. J Fungi (Basel) 2019;5:E22. [PMID: 30841504 DOI: 10.3390/jof5010022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
54 Buck TM, Wijnholds J. Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays. Int J Mol Sci 2020;21:E4197. [PMID: 32545533 DOI: 10.3390/ijms21124197] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
55 Blažević A, Hofland J, Hofland LJ, Feelders RA, de Herder WW. Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum. Endocr Relat Cancer 2018;25:R115-30. [PMID: 29233841 DOI: 10.1530/ERC-17-0380] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
56 Giampieri R, Ziranu P, Daniele B, Zizzi A, Ferrari D, Lonardi S, Zaniboni A, Cavanna L, Rosati G, Casagrande M, Pella N, Demurtas L, Zampino MG, Sozzi P, Pusceddu V, Germano D, Lai E, Zagonel V, Codecà C, Libertini M, Puzzoni M, Labianca R, Cascinu S, Scartozzi M. From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy. Cancers (Basel) 2020;12:E1330. [PMID: 32456056 DOI: 10.3390/cancers12051330] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
57 Andersson Y, Fleten KG, Abrahamsen TW, Reed W, Davidson B, Flatmark K. Anti-Angiogenic Treatment in Pseudomyxoma Peritonei-Still a Strong Preclinical Rationale. Cancers (Basel) 2021;13:2819. [PMID: 34198773 DOI: 10.3390/cancers13112819] [Reference Citation Analysis]
58 Sun JY, Zhao ZW, Li WM, Yang G, Jing PY, Li P, Dang HZ, Chen Z, Zhou YA, Li XF. Knockdown of MALAT1 expression inhibits HUVEC proliferation by upregulation of miR-320a and downregulation of FOXM1 expression. Oncotarget 2017;8:61499-509. [PMID: 28977880 DOI: 10.18632/oncotarget.18507] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
59 Agioutantis PC, Loutrari H, Kolisis FN. Computational Analysis of Transcriptomic and Proteomic Data for Deciphering Molecular Heterogeneity and Drug Responsiveness in Model Human Hepatocellular Carcinoma Cell Lines. Genes (Basel) 2020;11:E623. [PMID: 32517019 DOI: 10.3390/genes11060623] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Teng Y, Guo B, Mu X, Liu S. KIF26B promotes cell proliferation and migration through the FGF2/ERK signaling pathway in breast cancer. Biomed Pharmacother 2018;108:766-73. [PMID: 30248545 DOI: 10.1016/j.biopha.2018.09.036] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
61 Hamamoto J, Yasuda H, Nonaka Y, Fujiwara M, Nakamura Y, Soejima K, Betsuyaku T. The FGF2 aptamer inhibits the growth of FGF2-FGFR pathway driven lung cancer cells. Biochem Biophys Res Commun 2018;503:1330-4. [PMID: 30005872 DOI: 10.1016/j.bbrc.2018.07.044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
62 Djurdjevic P, Jovanovic D, Baskic D, Popovic S. Antiapoptotic Proteins mcl-1 and bcl-2 as well as Growth Factors FGF and VEGF Influence Survival of Peripheral Blood and Bone Marrow Chronic Lymphocytic Leukemia Cells. Serbian Journal of Experimental and Clinical Research 2020;21:133-9. [DOI: 10.2478/sjecr-2018-0025] [Reference Citation Analysis]
63 Zhang S, Huang J, Zhang L, Gu J, Song Q, Cai Y, Zhong J, Zhong H, Deng Y, Zhu W, Zhao J, Deng N. Fermentation, Purification, and Tumor Inhibition of a Disulfide-Stabilized Diabody Against Fibroblast Growth Factor-2. Front Oncol 2021;11:585457. [PMID: 33718141 DOI: 10.3389/fonc.2021.585457] [Reference Citation Analysis]
64 Cui X, Xin H, Peng H, Chen Y. Comprehensive bioinformatics analysis of the mRNA profile of PLCE1 knockdown in esophageal squamous cell carcinoma. Mol Med Rep 2017;16:5871-80. [PMID: 28849204 DOI: 10.3892/mmr.2017.7318] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Maehara O, Suda G, Natsuizaka M, Ohnishi S, Komatsu Y, Sato F, Nakai M, Sho T, Morikawa K, Ogawa K, Shimazaki T, Kimura M, Asano A, Fujimoto Y, Ohashi S, Kagawa S, Kinugasa H, Naganuma S, Whelan KA, Nakagawa H, Nakagawa K, Takeda H, Sakamoto N. Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma. Carcinogenesis 2017;38:1073-83. [PMID: 28927233 DOI: 10.1093/carcin/bgx095] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
66 Yu X, Wang Y, Tan X, Li M. Upregulation of fibroblast growth factor 2 contributes to endometriosis through SPRYs/DUSP6/ERK signaling pathway. Acta Histochem 2021;123:151749. [PMID: 34224989 DOI: 10.1016/j.acthis.2021.151749] [Reference Citation Analysis]
67 Hou F, Dai Y, Fan CY, Suen JY, Richter GT. Estrogen is involved in hemangioma regression associated with mast cells. Orphanet J Rare Dis 2018;13:181. [PMID: 30340617 DOI: 10.1186/s13023-018-0928-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Labrèche C, Cook DP, Abou-Hamad J, Pascoal J, Pryce BR, Al-Zahrani KN, Sabourin LA. Periostin gene expression in neu-positive breast cancer cells is regulated by a FGFR signaling cross talk with TGFβ/PI3K/AKT pathways. Breast Cancer Res 2021;23:107. [PMID: 34809697 DOI: 10.1186/s13058-021-01487-8] [Reference Citation Analysis]
69 Pradhan AK, Maji S, Das SK, Emdad L, Sarkar D, Fisher PB. MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein. Cancer Metastasis Rev 2020;39:769-81. [PMID: 32410111 DOI: 10.1007/s10555-020-09886-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
70 Hsieh MJ, Huang C, Lin CC, Tang CH, Lin CY, Lee IN, Huang HC, Chen JC. Basic fibroblast growth factor promotes doxorubicin resistance in chondrosarcoma cells by affecting XRCC5 expression. Mol Carcinog 2020;59:293-303. [PMID: 31916307 DOI: 10.1002/mc.23153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
71 Mikesova J, Miliaieva D, Stenclova P, Kindermann M, Vuckova T, Madlikova M, Fabry M, Veverka V, Schimer J, Krejci P, Stehlik S, Cigler P. Nanodiamonds as traps for fibroblast growth factors: Parameters influencing the interaction. Carbon 2022. [DOI: 10.1016/j.carbon.2022.04.017] [Reference Citation Analysis]
72 Chioni AM, Grose RP. Biological Significance and Targeting of the FGFR Axis in Cancer. Cancers (Basel) 2021;13:5681. [PMID: 34830836 DOI: 10.3390/cancers13225681] [Reference Citation Analysis]
73 Tirpe A, Gulei D, Tirpe GR, Nutu A, Irimie A, Campomenosi P, Pop LA, Berindan-Neagoe I. Beyond Conventional: The New Horizon of Anti-Angiogenic microRNAs in Non-Small Cell Lung Cancer Therapy. Int J Mol Sci 2020;21:E8002. [PMID: 33121202 DOI: 10.3390/ijms21218002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Zhao S, Zhang X, Chen S, Zhang S. Natural antisense transcripts in the biological hallmarks of cancer: powerful regulators hidden in the dark. J Exp Clin Cancer Res 2020;39:187. [PMID: 32928281 DOI: 10.1186/s13046-020-01700-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
75 Bębnowska D, Hrynkiewicz R, Grywalska E, Pasiarski M, Sosnowska-Pasiarska B, Smarz-Widelska I, Góźdź S, Roliński J, Niedźwiedzka-Rystwej P. Immunological Prognostic Factors in Multiple Myeloma. Int J Mol Sci 2021;22:3587. [PMID: 33808304 DOI: 10.3390/ijms22073587] [Reference Citation Analysis]
76 Shee K, Yang W, Hinds JW, Hampsch RA, Varn FS, Traphagen NA, Patel K, Cheng C, Jenkins NP, Kettenbach AN, Demidenko E, Owens P, Faber AC, Golub TR, Straussman R, Miller TW. Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer. J Exp Med 2018;215:895-910. [PMID: 29436393 DOI: 10.1084/jem.20171818] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 9.8] [Reference Citation Analysis]
77 Wong A, Sykora C, Rogers L, Higginbotham J, Wang J. Modified Nanoantibodies Increase Sensitivity in Avidin-Biotin Immunohistochemistry. Appl Immunohistochem Mol Morphol 2018;26:682-8. [PMID: 28059871 DOI: 10.1097/PAI.0000000000000488] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
78 Brough D, Pelegrin P, Nickel W. An emerging case for membrane pore formation as a common mechanism for the unconventional secretion of FGF2 and IL-1β. J Cell Sci 2017;130:3197-202. [PMID: 28871048 DOI: 10.1242/jcs.204206] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]